Ionis Pharmaceuticals Ownership | Who Owns Ionis Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Ionis Pharmaceuticals Ownership Summary


Ionis Pharmaceuticals is owned by 48.37% institutional investors, 0.61% insiders, and 51.02% retail investors. Dld asset management, lp is the largest institutional shareholder, holding 15.71% of IONS shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.66% of its assets in Ionis Pharmaceuticals shares.

IONS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockIonis Pharmaceuticals48.37%0.61%51.02%
SectorHealthcare Stocks 35.49%11.78%52.72%
IndustryBiotech Stocks 34.84%11.71%53.45%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Dld asset management, lp25.00M15.71%$34.63B
Fmr24.56M15.35%$1.84B
Capital world investors21.19M13.24%$1.59B
Vanguard group16.44M10.23%$1.30B
Blackrock10.32M7.09%$491.90M
Blackrock funding, inc. /de10.44M6.53%$784.13M
Lombard odier asset management (europe)6.49M4.08%$8.96M
Wellington management group llp6.39M3.99%$479.96M
T. rowe price investment management6.16M3.85%$462.48M
Two sigma investments, lp5.86M3.66%$439.85M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tweedy, browne2.28M13.57%$170.88M
Boone capital management500.52K11.51%$37.58M
Davern capital partners, lp386.90K7.97%$29.05M
Orion investment225.01K5.36%$16.90M
Privium fund management b.v.290.02K4.53%$21.78M
Exome asset management110.06K4.27%$8.26M
Bellevue group1.82M3.25%$136.56M
Vestal point capital, lp1.07M3.18%$70.33M
Sicart associates159.41K3.08%$11.97M
Healthinvest partners ab27.87K3.03%$9.40M

Top Buyers

HolderShares% AssetsChange
Dld asset management, lp25.00M2.48%25.00M
Lombard odier asset management (europe)6.49M0.45%6.49M
Capital world investors21.19M0.22%3.23M
Two sigma investments, lp5.86M0.35%3.20M
Royal bank of canada3.80M0.05%2.68M

Top Sellers

HolderShares% AssetsChange
Bellevue group1.82M3.25%-2.98M
T. rowe price investment management6.16M0.32%-2.95M
Orbimed advisors---2.54M
Bvf inc/il---1.91M
Citadel advisors942.53K0.01%-1.19M

New Positions

HolderShares% AssetsChangeValue
Dld asset management, lp25.00M2.48%25.00M$34.63B
Lombard odier asset management (europe)6.49M0.45%6.49M$8.96M
Vanguard fiduciary trust1.02M0.02%1.02M$76.92M
Balyasny asset management768.65K0.05%768.65K$30.37M
Perceptive advisors504.00K0.74%504.00K$37.85M

Sold Out

HolderChange
Stone house investment management-3.00
Mv capital management-3.00
Wealthtrak capital management-5.00
Bryn mawr trust-5.00
Bare financial services-6.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026320-39.16%77,385,968-54.54%480.43%144-47.83%98-32.41%
Dec 31, 2025388-18.32%92,594,267-53.74%570.36%211-18.53%100-14.53%
Sep 30, 202544917.23%194,303,01714.72%1221.08%24117.56%1156.48%
Jun 30, 20253793.55%169,594,6551.94%1060.97%20128.85%108-14.29%
Mar 31, 202515-96.08%14,001,670-91.30%80.08%6-96.65%6-94.92%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S11.01M6.66%-84.03K
Fidelity Growth Compy Commingled Pl O9.71M6.16%90.97K
Fidelity Growth Company Fund8.41M5.09%301.10K
American Funds Growth Fund of Amer A7.67M4.64%1.27M
Capital Group Growth Fnd of Amer Comp7.67M4.62%1.27M
BB Biotech AG Ord6.22M3.84%-1.63M
Vanguard Total Stock Mkt Idx Inv5.00M3.02%-153.46K
American Funds New Economy A4.72M2.86%845.41K
Capital Group New Economy Comp4.72M2.85%845.41K
Vanguard US Total Market Shares ETF4.50M2.83%256.36K

Recent Insider Transactions


DateNameRoleActivityValue
May 14, 2026Monia Brett P Chief Executive OfficerSell$253.35K
May 13, 2026Monia Brett P Chief Executive OfficerSell$102.67K
May 04, 2026LOSCALZO JOSEPH-Sell$1.34M
May 04, 2026LOSCALZO JOSEPH-Sell$4.46M
May 01, 2026KLEIN JOSEPH III-Sell$106.53K

Insider Transactions Trends


DateBuySell
2026 Q2-15
2026 Q1-54
2025 Q4-33
2025 Q3-40
2025 Q213

IONS Ownership FAQ


Who Owns Ionis Pharmaceuticals?

Ionis Pharmaceuticals shareholders are primarily institutional investors at 48.37%, followed by 0.61% insiders and 51.02% retail investors. The average institutional ownership in Ionis Pharmaceuticals's industry, Biotech Stocks , is 34.84%, which Ionis Pharmaceuticals exceeds.

Who owns the most shares of Ionis Pharmaceuticals?

Ionis Pharmaceuticals’s largest shareholders are Dld asset management, lp (25M shares, 15.71%), Fmr (24.56M shares, 15.35%), and Capital world investors (21.19M shares, 13.24%). Together, they hold 44.30% of Ionis Pharmaceuticals’s total shares outstanding.

Does Blackrock own Ionis Pharmaceuticals?

Yes, BlackRock owns 7.09% of Ionis Pharmaceuticals, totaling 10.32M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 491.9M$. In the last quarter, BlackRock increased its holdings by 549.14K shares, a 5.62% change.

Who is Ionis Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tweedy, browne is Ionis Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 13.57% of its assets in 2.28M Ionis Pharmaceuticals shares, valued at 170.88M$.

Who is the top mutual fund holder of Ionis Pharmaceuticals shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Ionis Pharmaceuticals shares, with 6.66% of its total shares outstanding invested in 11.01M Ionis Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools